JPL Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
JPL Wealth Management's MRNA Position: Q2 2026 in Review
JPL Wealth Management increased its Moderna (MRNA) stake by 100% in Q2 2026, buying an estimated $259 and bringing the position to 10 shares worth $701. The position accounts for ﹤0.01% of the portfolio, ranked #1358.
JPL Wealth Management first reported a position in MRNA in Q3 2025 and has held it in 3 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- JPL Wealth Management held 10 shares of Moderna worth $701 as of Q2 2026.
- JPL Wealth Management bought 5 Moderna shares in Q2 2026, an estimated $259.
- Moderna made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1358 holding.
- JPL Wealth Management first reported a position in Moderna in Q3 2025 and has held it in 3 quarters since.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.